noom glp 1 reviews GLP-1 Review 2026: Great App but Hidden Costs Why We Launched Noom GLP-1RX

Individuals with a BMI of 3034.9 kg/m (or 27.532.4 kg/m for the specified ethnic groups) may be considered if they have at least one weight-related comorbidity

Another recent study showed that liraglutide can activate the GLP-1 receptor on appetite-regulating neurons in the arcuate nucleus (ARC), which may mediate its long-term weight loss effects[131]

Safety Considerations and Adverse Effects While GLP-1 receptor agonists offer numerous benefits, clinicians should be mindful of potential adverse effects

Evidence from the UKPDS study supports its role in reducing diabetes-related endpoints, including myocardial infarction and all-cause mortality

In support of this, ICV administration of GLP-1 in rats has been shown to attenuate the fasting-induced rise in NPY/AgRP expression and decreases fasting-induced inhibition of POMC/CART expression in the ARC (Seo et al., 2008)

Medically Reviewed | Updated: February 2026 Category: GLP-1 & Weight Loss | Reading Time: 8 min If youre preparing to start a GLP-1 receptor agonist whether thats semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), or another agent in this class baseline lab testing is one of the most important steps you can take before your first dose